Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Januar 2025

Genmab — Januar 2025

Planlagt Fastgjort Låst Flyttet Genmab
702 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • P Offline
    P Offline
    ProinvestorNEWS
    wrote on sidst redigeret af
    #421

    Claus Henrik Johansen er sundhedsinvestor samt stifter og CEO for investeringsafdelingen "IA Invest Global Health Invest". Han har i mere end 20 år arbejdet med sundhedsaktier og -selskaber.

    Se med, når han giver sit bud på de tre vigtigste temaer de næste 1-3 år. Han fortæller også, hvorfor han mener, man bør kigge i retning af sundhedsaktier, og hvordan man kan opdele de forskellige selskaber i kategorier, når man skal opbygge sin portefølje. Video: https://proinvestor.com/boards/124357

    1 Reply Last reply
    0
    • B Offline
      B Offline
      bikube
      wrote on sidst redigeret af
      #422

      Sanofi får godkendt udfordrer til Genmab-middel i EU. Det siger MedWatch i dag kl7,37.

      1 Reply Last reply
      0
      • L Offline
        L Offline
        lahn1
        wrote on sidst redigeret af
        #423

        Er Carvykti grundt til lidt skuffenede Dara salg i Q4 ?

        1 Reply Last reply
        0
        • SolsenS Offline
          SolsenS Offline
          Solsen
          wrote on sidst redigeret af
          #424

          Vand på erzo møllen

          1 Reply Last reply
          0
          • Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktør
            wrote on sidst redigeret af
            #425

            Godmorgen 🙂

            1 Reply Last reply
            0
            • L Offline
              L Offline
              LP90
              wrote on sidst redigeret af
              #426

              Godmorgen 🙂

              1 Reply Last reply
              0
              • S Offline
                S Offline
                Stroka
                wrote on sidst redigeret af
                #427

                God morgen 🙂

                1 Reply Last reply
                0
                • P Offline
                  P Offline
                  ProinvestorNEWS
                  wrote on sidst redigeret af
                  #428

                  Genmab får sakset 15 pct. af kursmålet hos amerikansk børshus https://proinvestor.com/investornyt/1268962/genmab-far-sakset-15-pct-af-kursmalet-hos-amerikansk-borshus

                  1 Reply Last reply
                  0
                  • M Offline
                    M Offline
                    mobbyduck1
                    wrote on sidst redigeret af
                    #429

                    det ligner et hak i tuden i dag, desværre....

                    1 Reply Last reply
                    0
                    • J Offline
                      J Offline
                      JKY_VH
                      wrote on sidst redigeret af
                      #430

                      Ja GS føler åbenbart trang til at lukke en "bæ" ud. Jeg synes ikke umiddelbart at der er nogen forklaring bortset fra usikkerhed omkring Hexa og det er jo ingen nyhed.

                      1 Reply Last reply
                      0
                      • M Offline
                        M Offline
                        mobbyduck1
                        wrote on sidst redigeret af
                        #431

                        genmab er så billig, at man får alt gratis, hvis man trækker Darzalex og egenkapital fra. Det er helt til grin

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #432

                          New Mount Sinai Trial Reveals Major Advance in Treatment of Aggressive Lymphoma https://www.mountsinai.org/about/newsroom/2025/new-mount-sinai-trial-reveals-major-advance-in-treatment-of-aggressive-lymphoma

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #433

                            Danish biotech Genmab (CPH: GMAB) today announced it has named Leslie Amendola senior vice president and general manager of its US business. https://www.thepharmaletter.com/genmab-names-us-general-manager https://www.linkedin.com/posts/genmab_newsupdate-activity-7288199613231120386-i8xM/

                            1 Reply Last reply
                            0
                            • Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktør
                              wrote on sidst redigeret af
                              #434

                              Godmorgen 🙂

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #435

                                why would Genmab sponsor anything for hemophilia care? https://www.surveymonkey.com/r/H7HFWZ5 (could it have something to do with bleeding side effects from Tisotumab?)( i am assuming it is not related to Hemab, why would it go via Genmab
                                )

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #436

                                  Brian Slomovitz, MD, MS, FACOG
                                  @GynCancerMD

                                  Honored to discuss our practice changing study using tisotumab vedotin in patients recurrent cervical cancer. Led to full FDA approval https://x.com/GynCancerMD/status/1882780591390921153 -Podcast

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #437

                                    Bichoy Gabra, R.Ph., Ph.D.
                                    @BichoyGabra
                                    Tivdak (tisotumab vedotin-tftv) mechanism of action in metastatic cervical cancer https://x.com/BichoyGabra/status/1881714400291168285

                                    1 Reply Last reply
                                    0
                                    • L Offline
                                      L Offline
                                      lahn1
                                      wrote on sidst redigeret af
                                      #438

                                      Hmm that interesting noting relevant in the pileline so could be bleeding issue with TV. Did we see any bleeding issues in Rina-s ?

                                      1 Reply Last reply
                                      0
                                      • G Offline
                                        G Offline
                                        gentogen
                                        wrote on sidst redigeret af
                                        #439

                                        In innovaTV 204, TRAEs of bleeding occurred in 39 patients (39%) and were mostly grades 1 or 2;

                                        1 Reply Last reply
                                        0
                                        • G Offline
                                          G Offline
                                          gentogen
                                          wrote on sidst redigeret af
                                          #440

                                          Checking your browser - reCAPTCHA

                                          favicon

                                          (pmc.ncbi.nlm.nih.gov)

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper